InnoPharmax Inc. (TPEX:4172)
Taiwan · Delayed Price · Currency is TWD 12.55
-0.30 (-2.33%)
May 29, 2026, 1:54 PM CST
InnoPharmax Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -184.4 | -99.29 | -70.83 | -103.18 | -92.97 |
Depreciation & Amortization | 6.29 | 6.55 | 7.2 | 8.35 | 9.48 |
Other Amortization | 0.04 | 0.06 | 0.04 | 0.02 | - |
Loss (Gain) From Sale of Assets | - | - | - | 0.03 | - |
Asset Writedown & Restructuring Costs | 0.08 | - | 1.4 | - | 3.16 |
Loss (Gain) From Sale of Investments | - | - | - | - | 2 |
Loss (Gain) on Equity Investments | 10.24 | 8.12 | 9.3 | 5.82 | 13.32 |
Stock-Based Compensation | 0.38 | 1.24 | 1.76 | 2.37 | 0.66 |
Provision & Write-off of Bad Debts | - | 6.09 | - | -0.5 | -0.83 |
Other Operating Activities | 3.51 | 3.24 | 0.22 | 0.22 | 0.29 |
Change in Accounts Receivable | 2.71 | 2.42 | -6.96 | 0.5 | 6.47 |
Change in Inventory | 3.22 | 3.9 | 7.78 | -14.44 | 29.18 |
Change in Accounts Payable | 6.91 | -4.16 | 5.72 | - | -26.87 |
Change in Unearned Revenue | 1.2 | 2.26 | - | - | - |
Change in Other Net Operating Assets | 15.64 | -6.67 | -4.21 | 0.75 | 6.09 |
Operating Cash Flow | -134.19 | -76.22 | -48.57 | -100.08 | -50.03 |
Capital Expenditures | -0.28 | -0.53 | -0.4 | - | -1.45 |
Sale of Property, Plant & Equipment | - | - | - | 0.03 | - |
Sale (Purchase) of Intangibles | - | -0.06 | - | -0.13 | - |
Investment in Securities | 69.93 | -14.56 | -48.91 | 32.71 | -36.22 |
Other Investing Activities | -0.35 | -0.44 | -0.7 | -1.3 | 1.06 |
Investing Cash Flow | 69.31 | -15.59 | -50.01 | 31.32 | -36.6 |
Short-Term Debt Issued | - | - | - | 23.27 | - |
Total Debt Issued | - | - | - | 23.27 | - |
Short-Term Debt Repaid | - | -1.5 | -11.77 | - | -20 |
Long-Term Debt Repaid | -4.57 | -4.48 | -4.42 | -4.5 | -4.42 |
Total Debt Repaid | -4.57 | -5.98 | -16.19 | -4.5 | -24.42 |
Net Debt Issued (Repaid) | -4.57 | -5.98 | -16.19 | 18.77 | -24.42 |
Issuance of Common Stock | - | 225.16 | 113.6 | - | 20.15 |
Financing Cash Flow | -4.57 | 219.18 | 97.41 | 18.77 | -4.26 |
Net Cash Flow | -69.45 | 127.37 | -1.17 | -49.98 | -90.89 |
Free Cash Flow | -134.47 | -76.75 | -48.97 | -100.08 | -51.48 |
Free Cash Flow Margin | -194.92% | -237.64% | -106.29% | -343.51% | -107.11% |
Free Cash Flow Per Share | -1.25 | -0.79 | -0.53 | -1.15 | -0.60 |
Cash Interest Paid | 0.39 | 0.32 | 0.19 | 0.06 | 0.04 |
Cash Income Tax Paid | 0.06 | 0.18 | -0.1 | - | - |
Levered Free Cash Flow | -67.17 | -45.78 | -34.59 | -64.47 | -159.12 |
Unlevered Free Cash Flow | -66.93 | -45.59 | -34.36 | -64.31 | -158.87 |
Change in Working Capital | 29.67 | -2.23 | 2.33 | -13.2 | 14.87 |